Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Results of EAHP's 2018 Survey on Medicines Shortages

Autor: Danzon, Patricia M., Kandolf Sekulovic, L., Guo, J., Agarwala, S., Hauschild, A., McArthur, G., Cinat, G., Wainstein, A., Caglevic, C., Lorigan, P., Gogas, H., Alvarez, M., Duncombe, R., Lebbe, C., Peris, K., Rutkowski, P., Stratigos, A., Forsea, A. M., De La Cruz Merino, L., Kukushkina, M., Dummer, R., Hoeller, C., Gorry, C., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Arenberger, P., Bylaite-Bucinskiene, M., Babovic, N., Banjin, M., Putnik, K., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Ymeri, A., Stojkovski, I., Garbe, C., Miljković, Nenad, Gibbons, Nicholas, Batista, Aida, Fitzpatrick, Raymond William, Underhill, Jonathan, Horák, Petr

Publikováno v: Danzon, P M, Kandolf Sekulovic, L, Guo, J, Agarwala, S, Hauschild, A, McArthur, G, Cinat, G, Wainstein, A, Caglevic, C, Lorigan, P, Gogas, H, Alvarez, M, Duncombe, R, Lebbe, C, Peris, K, Rutkowski, P, Stratigos, A, Forsea, A M, De La Cruz Merino, L, Kukushkina, M, Dummer, R, Hoeller, C, Gorry, C, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Arenberger, P, Bylaite-Bucinskiene, M, Babovic, N, Banjin, M, Putnik, K, Todorovic, V, Kirov, K, Ocvirk, J, Zhukavets, A, Ymeri, A, Stojkovski, I, Garbe, C, Miljković, N, Gibbons, N, Batista, A, Fitzpatrick, R W, Underhill, J & Horák, P 2019, ' Results of EAHP's 2018 Survey on Medicines Shortages ', European Journal of Hospital Pharmacy, pp. 60-65 . https://doi.org/10.1136/ejhpharm-2018-001835

Aims and objectives: \ud The aim of the 2018 EAHP Survey on Medicines Shortages was to provide a clearer picture on the issue of medicines shortages, including the impact on hospital pharmacists' time, budgets and the effect on patient care. Methods:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3efc7779c81526493df67f1225dc2b4b

POSA411 Real World Outcomes of First Line Pembrolizumab Monotherapy for Advanced PD-L1 Positive Non-Small Cell Lung Cancer

Autor: Chu, R, Vegas, A, Gorry, C, Power, D

Publikováno v: In Value in Health January 2022 25(1) Supplement:S253-S253

POSA141 Cost Effectiveness Analysis of Pembrolizumab Monotherapy in Advanced PD-L1 ≥50% Non-Small Cell Lung Cancer (NSCLC) in the Irish Setting

Autor: Chu, R, Vegas, A, Gorry, C, Power, D

Publikováno v: In Value in Health January 2022 25(1) Supplement:S61-S61

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.